EGLN1 and non-small cell lung carcinoma: investigated the mRNA levels of PHD2 in 62 pairs of normal and NSCLC samples by RT-qPCR and found that PHD2 expression was significantly higher in lung cancer tissues than in the adjacent normal tissues.